Shuang Liu
Key Laboratory For Molecular Enzymology And Engineering
Changchun, China
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.
Journal: Molecular oncology
Published: March 04, 2025
The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.
Journal: Cancer research
Published: September 06, 2023
Anti-inflammatory effect and mechanism of catalpol in various inflammatory diseases.
Journal: Drug development research
Published: April 10, 2023
c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia.
Journal: Apoptosis : an international journal on programmed cell death
Published: July 10, 2022
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia.
Journal: Journal of cellular and molecular medicine
Published: October 31, 2021
Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance.
Journal: Experimental hematology
Published: September 06, 2021
Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer.
Journal: Cancer chemotherapy and pharmacology
Published: July 24, 2020
Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis.
Journal: Frontiers in oncology
Published: May 26, 2020
Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.
Journal: Cancer management and research
Published: January 20, 2020
Last Updated: 09/26/2026